Lyophilized preparation containing antibodies to the EGF receptor

Details for Australian Patent Application No. 2002358533 (hide)

Owner Merck Patent GmbH

Inventors Mahler, Hanns-Christian; Kruger, Ludwig; Muller, Robert; Haas, Udo; Zobel, Hans-Peter; Bachmann, Christiane; Martini-Marr, Ulrike

Agent Davies Collison Cave

Pub. Number AU-B-2002358533

PCT Number PCT/EP02/13223

PCT Pub. Number WO2003/053465

Priority 101 63 459.5 21.12.01 DE

Filing date 25 November 2002

Wipo publication date 9 July 2003

Acceptance publication date 15 January 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 101 63 459.5 21.12.01 DE

2 October 2003 Application Open to Public Inspection

  Published as AU-B-2002358533

15 January 2009 Application Accepted

  Published as AU-B-2002358533

14 May 2009 Standard Patent Sealed

23 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002358534-SUBSTITUTED PHENYL DERIVATIVES

2002358532-METHOD FOR ANALYZING TRANSLATION-CONTROLLED GENE EXPRESSION